33 Medical, Inc.
Home
Our Team
Our Products
  • NuvoDisc Microgel™
  • Tekon TDR™
Clinical Trials
Contact Us
33 Medical, Inc.
Home
Our Team
Our Products
  • NuvoDisc Microgel™
  • Tekon TDR™
Clinical Trials
Contact Us
More
  • Home
  • Our Team
  • Our Products
    • NuvoDisc Microgel™
    • Tekon TDR™
  • Clinical Trials
  • Contact Us
  • Home
  • Our Team
  • Our Products
    • NuvoDisc Microgel™
    • Tekon TDR™
  • Clinical Trials
  • Contact Us

NuvoDisc Microgel™

CLINICAL OBJECTIVES

  • Relieve/reduce back pain for 1 + year
  • Improve functionality and range of motion
  • Delay or potentially avoid surgery

SURGICAL PROCEDURE

  • Minimally invasive disc injection
  • Image-guided access to the nucleus pulposus (center of disc)
  • Local anesthesia with conscious sedation
  • Oblique percutaneous approach
  • Single injection 10 minutes after patient preparation
  • Patients are immediately mobile after procedure

Video

Discover More

33 Medical, Inc.

 NuvoDisc Microgel and Tekon TDR are an investigational devices which are not approved or cleared by the FDA in the United States. 


Copyright © 2024 33 Medical, Inc. - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept